AU2003239717A1 - Card-4 molecules and uses thereof - Google Patents

Card-4 molecules and uses thereof

Info

Publication number: AU2003239717A1
Authority: AU; Australia
Prior art keywords: molecules; card
Prior art date: 2002-05-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003239717A

Other versions

AU2003239717A8 (en

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Institut Pasteur

Original Assignee

Institut Pasteur

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-22

Filing date

2003-05-22

Publication date

2003-12-02

2003-05-22 Application filed by Institut Pasteur filed Critical Institut Pasteur

2003-12-02 Publication of AU2003239717A1 publication Critical patent/AU2003239717A1/en

2003-12-02 Publication of AU2003239717A8 publication Critical patent/AU2003239717A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pulmonology (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Hematology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)

AU2003239717A 2002-05-22 2003-05-22 Card-4 molecules and uses thereof Abandoned AU2003239717A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US15448502A	2002-05-22	2002-05-22
US10/154,485		2002-05-22
US35238103A	2003-01-27	2003-01-27
US10/352,381		2003-01-27
PCT/IB2003/002597 WO2003097684A2 (en)	2002-05-22	2003-05-22	Card-4 molecules and uses thereof

Publications (2)

Publication Number	Publication Date
AU2003239717A1 true AU2003239717A1 (en)	2003-12-02
AU2003239717A8 AU2003239717A8 (en)	2003-12-02

Family

ID=29552749

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003239717A Abandoned AU2003239717A1 (en)	2002-05-22	2003-05-22	Card-4 molecules and uses thereof

Country Status (5)

Country	Link
EP (1)	EP1509544A2 (en)
JP (1)	JP2006512045A (en)
AU (1)	AU2003239717A1 (en)
CA (1)	CA2486603A1 (en)
WO (1)	WO2003097684A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002053765A1 (en) *	2000-12-29	2002-07-11	Millennium Pharmaceuticals, Inc.	Novel molecules of the card-related protein family and used thereof

2003
- 2003-05-22 WO PCT/IB2003/002597 patent/WO2003097684A2/en not_active Application Discontinuation
- 2003-05-22 CA CA002486603A patent/CA2486603A1/en not_active Abandoned
- 2003-05-22 AU AU2003239717A patent/AU2003239717A1/en not_active Abandoned
- 2003-05-22 EP EP03732905A patent/EP1509544A2/en not_active Withdrawn
- 2003-05-22 JP JP2004506357A patent/JP2006512045A/en active Pending

Also Published As

Publication number	Publication date
WO2003097684A2 (en)	2003-11-27
WO2003097684A3 (en)	2004-03-11
JP2006512045A (en)	2006-04-13
EP1509544A2 (en)	2005-03-02
CA2486603A1 (en)	2003-11-27
WO2003097684A8 (en)	2004-04-29
AU2003239717A8 (en)	2003-12-02

Publication	Publication Date	Title
AU2003270341A1 (en)	2004-03-29	Modified asialo-interferons and uses thereof
AU2003266321A1 (en)	2004-04-08	Tetrahydropyrimidine-2-one derivatives and their uses
AU2003272187A1 (en)	2004-01-06	Novel nanoparticles and use thereof
AU2003232821A1 (en)	2003-12-02	Novel phospholipases and uses thereof
AU2002258388A1 (en)	2002-09-19	Narc8 programmed cell-death-associated molecules and uses thereof
AU2003205381A1 (en)	2003-09-02	Hpma-polyamine conjugates and uses therefore
EP1572168A3 (en)	2005-09-22	Anti-infarction molecules
AU2003300815A1 (en)	2004-06-30	Protein modification and maintenance molecules
AU2003281691A1 (en)	2004-02-16	Furoisoquinoline derivative and use thereof
AU2003205353A1 (en)	2003-09-02	Protein modification and maintenance molecules
AU2003268023A1 (en)	2004-02-09	Protein modification and maintenance molecules
AU2003231827A1 (en)	2003-12-12	Pseudo-tissues and uses thereof
AUPS187002A0 (en)	2002-05-30	Condition-specific molecules and uses therefor
AU2003298739A1 (en)	2004-06-18	Intermedin and its uses
AU2003228355A1 (en)	2003-10-13	Adipocytes and uses thereof
AU2002953223A0 (en)	2003-01-02	Novel therapeutic molecules and uses thereof
AU2003302173A1 (en)	2004-07-14	Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003239871A1 (en)	2003-12-12	Protein modification and maintenance molecules
AU2003231981A1 (en)	2003-10-13	Protein modification and maintenance molecules
AU2003286392A1 (en)	2004-06-18	1microarrays and production thereof
AU2003263329A1 (en)	2004-03-29	Foxp2 and uses thereof
AU2003228397A1 (en)	2003-10-20	HAUSP-p53 INTERACTION AND USES THEREOF
AU2003263326A1 (en)	2004-03-29	Foxp1 and uses thereof
AU2003218226A1 (en)	2003-09-29	Transcription factor modulators and uses thereof
AU2003219732A1 (en)	2003-09-04	Oligomeric molecules and uses thereof

Legal Events

Date	Code	Title	Description
2005-02-10	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase